SANOFI (SAN.PA) Financials
SAN.PA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 126.5 billion | 52.1 billion |
| 2023-09-30 | ? | ? |
| 2023-06-30 | 125.4 billion | 52.4 billion |
| 2023-03-31 | ? | ? |
SAN.PA Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 4.6 billion | -5.9 billion |
| 2023-09-30 | ? | ? |
| 2023-06-30 | 2.4 billion | 160.0 million |
| 2023-03-31 | ? | ? |
SAN.PA Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 2.0 billion |
| 2023-09-30 | 2.5 billion |
| 2023-06-30 | 3.4 billion |
| 2023-03-31 | 2.0 billion |
SAN.PA Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 8.7 billion | - | 2.0 billion |
| 2023-09-30 | 8.0 billion | - | - |
| 2023-06-30 | 8.0 billion | 16.4 billion | 2.1 billion |
| 2023-03-31 | 12.7 billion | - | - |
SAN.PA Shares Outstanding
SAN.PA Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 2.1 billion | 3.5 billion | 2.9 billion | - |
| 2023-09-30 | - | 1.7 billion | 2.6 billion | - |
| 2023-06-30 | 1.1 billion | 1.6 billion | 5.2 billion | - |
| 2023-03-31 | - | 1.6 billion | 2.6 billion | - |
SAN.PA Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 22.9 billion | 8.2 billion |
| 2023-09-30 | 12.7 billion | 3.8 billion |
| 2023-06-30 | 10.7 billion | 3.3 billion |
| 2023-03-31 | 10.9 billion | 3.1 billion |
SAN.PA
Price: €91.64
Dividend Yield: 0.04%
Forward Dividend Yield: 4.12%
Payout Ratio: 87.24%
Dividend Per Share: 3.76 EUR
Earnings Per Share: 4.30 EUR
P/E Ratio: 20.28
Exchange: PAR
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 1.7 million
Market Capitalization: 107.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 25
DGR3: 4.19%
DGR5: 3.30%
DGR10: 2.55%
DGR20: 30.00%